LEO Pharma’s innovation engine is fuelled by a global R&D organisation with more than 700 curious, expert scientists and specialists. Together with business development acquisitions and partnerships, we have built a substantial pipeline focused on covering several indications. By focusing on driving medical dermatology forward we are expanding our internal innovation and external partnerships to ensure we deliver on our highly ambitious R&D commitments.
Our current pipeline includes:
In addition, we explore opportunities to make treatment easier for patients through innovations within medical device technologies and digital solutions and services.